Vita Health Products Issues Voluntary Recall of Its Ranitidine Products in Canada

WINNIPEG, Manitoba, Oct. 25, 2019 /CNW/ -- As a precautionary measure, today Vita Health Products Inc. (the "Company") announced a voluntary Type I recall of all the Company's ranitidine products in Canada. This is due to the low level presence of N-nitrosodimethylamine (NDMA), an environmental contaminant and potential carcinogen found in water and foods, including meats, dairy products, and vegetables.  

The bulk active ingredient used in Vita Health's ranitidine products is sourced from a third party. Upon initial testing of these products, Health Canada did find low levels of NDMA. As a result, and per direction from the supplier, Vita Health made the decision to conduct a voluntary recall. Although Vita Health has not received any complaints or adverse events associated with these products, this action is consistent with the Company's commitment to consumer safety.

In September 2019, The U.S. Food and Drug Administration, Health Canada and European regulators alerted manufacturers that, as a result of third party testing, NDMA had been detected in some generic and brand versions of ranitidine. They requested all manufacturers voluntarily stop shipping and complete further testing on ranitidine products, which Vita Health immediately complied with.

The below products are impacted by this recall:

Consumers who have these products in their possession should return them to the place of purchase or call the Vita Health Customer Contact Centre at 1-877-637-7557, Monday-Friday 9 am-5:30 pm ET for further instruction.

For further information:

MEDIA CONTACT:
Nicole Hayes
Senior Manager, Corporate Communications
nhayes@nbty.com
1-631-200-2650

SOURCE Vita Health Products Inc.